US 12171750
Isoxazoline parasiticide formulations and methods for treating blepharitis
granted A61KA61K31/42A61K31/422
Quick answer
US patent 12171750 (Isoxazoline parasiticide formulations and methods for treating blepharitis) held by Tarsus Pharmaceuticals, Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tarsus Pharmaceuticals, Inc.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K47/26, A61K9/0048